Clinical Trial Update: Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sildenafil for exercise performance in idiopathic pulmonary fibrosis completed; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis
• Pulmonary Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Duke University | Conditions: Pulmonary Fibrosis, Hypertension, Pulmonary | Phase 3 | Status: COMPLETED | Results posted: 2013-08-23